New Treatments

Transforming TB Treatment

TB Alliance is leading the global effort to develop faster, simpler, and more effective cures for all forms of TB.

How We’re Doing It
Learn More:

Innovate to Eradicate

For 25 years, TB Alliance has led the global movement to discover, develop, and deliver new and improved TB treatments. After transforming drug-resistant TB therapy, we’re working on a next suite of innovations that could set the stage for ending TB. Our 25th Anniversary series shares perspectives from various thought leaders on the past, present, and future of TB drug development.

Learn More

The Latest from TB Alliance

Impact of BPaL/M: Shorter Care. More Lives Saved. Lower Costs.

Findings from Johns Hopkins University research show that BPaL/M is on track to save 191k lives and US$1.29B by 2034—while boosting treatment completion and success. Read more.

TB By The Numbers

Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 24 seconds — about 1.3 million people every year.
Get the Facts
6-Months
Too many people with TB are still given older regimens that take too long to cure, are too complicated to administer, and can be toxic.
How We’re Doing It
+ Projects
Promise in the pipeline means new hope in stopping TB.
Explore our Pipeline
REACHING THOSE IN NEED

Delivering Treatments

TB Alliance’s mission is not complete until new drugs are in the hands of those who need them.

How We’re Doing It
More News:
TRANSFORMING TB TREATMENT

Charting the Course

We’ve all come to know the impact of infectious diseases, but we also know the power of science.

How We’re Doing It
More News:

TB Alliance manages the largest pipeline of new TB drugs in history.

View Portfolio

Latest News

See All